Neuralink and Brain-Computer Interfaces: Market Predictions

Article

The Final Frontier of Technology Brain computer interfaces promise to transform human capability. Here's the market view. Neuralink Progress First human trials are underway. Markets expect meaningful results data in 2026. FDA Pathway Full regulatory approval for therapeutic applications expected 2027 2030. Competition Synchron, Blackrock Neurotech, and others are advancing alternative approaches. Application Timeline Medical Paralysis treatment leading, with broader neurological conditions following Enhancement Consumer applications much further out, 10+ years Ethical Considerations Markets factor in regulatory and social acceptance challenges for enhancement use cases.